Ameritas Investment Partners’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $214K | Hold |
4,912
| – | – | 0.01% | 1251 |
|
|
2025
Q1 | $134K | Hold |
4,912
| – | – | ﹤0.01% | 1505 |
|
|
2024
Q4 | $198K | Buy |
4,912
+406
| +9% | +$16.3K | 0.01% | 1329 |
|
|
2024
Q3 | $213K | Buy |
4,506
+436
| +11% | +$20.6K | 0.01% | 1277 |
|
|
2024
Q2 | $121K | Hold |
4,070
| – | – | ﹤0.01% | 1609 |
|
|
2024
Q1 | $164K | Buy |
4,070
+295
| +8% | +$11.9K | 0.01% | 1429 |
|
|
2023
Q4 | $96.1K | Hold |
3,775
| – | – | ﹤0.01% | 1758 |
|
|
2023
Q3 | $52.5K | Buy |
3,775
+810
| +27% | +$11.3K | ﹤0.01% | 2079 |
|
|
2023
Q2 | $68.2K | Hold |
2,965
| – | – | ﹤0.01% | 1851 |
|
|
2023
Q1 | $87.9K | Hold |
2,965
| – | – | ﹤0.01% | 1618 |
|
|
2022
Q4 | $105K | Hold |
2,965
| – | – | ﹤0.01% | 1559 |
|
|
2022
Q3 | $64K | Buy |
2,965
+331
| +13% | +$7.15K | ﹤0.01% | 1809 |
|
|
2022
Q2 | $51K | Hold |
2,634
| – | – | ﹤0.01% | 1975 |
|
|
2022
Q1 | $111K | Hold |
2,634
| – | – | ﹤0.01% | 1572 |
|
|
2021
Q4 | $167K | Hold |
2,634
| – | – | 0.01% | 1338 |
|
|
2021
Q3 | $155K | Buy |
2,634
+367
| +16% | +$21.6K | 0.01% | 1400 |
|
|
2021
Q2 | $110K | Buy |
2,267
+1,422
| +168% | +$69K | ﹤0.01% | 1668 |
|
|
2021
Q1 | $33K | Hold |
845
| – | – | ﹤0.01% | 2316 |
|
|
2020
Q4 | $52K | Buy |
+845
| New | +$52K | ﹤0.01% | 1972 |
|